Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujun Cai

Showing results (211-220 of 299) with videos related to

Pageof 30
Sort By:
Annals of Translational Medicine|November 4, 2020
Association of circulating 25-Hydroxyvitamin D and its related genetic variations with hepatocellular carcinoma incidence and survivalHui Liu, Xia Jiang, Qiaohua Qiao, et al.
Cell Communication and Signaling : CCS|July 16, 2022
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growthJiahao Hu, Jiasheng Cao, Ren'an Jin, et al.
Molecular Cancer Therapeutics|March 5, 2016
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC ProgressionLiang Shi, Hui Lin, Gonghui Li, et al.
Aging|June 25, 2020
Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinomaGuangyi Jiang, Liang Shi, Xueyong Zheng, et al.
Surgery|March 29, 2025
Beta-catenin/sirtuin 1/farnesoid X receptor pathway promotion of portal vein ligation and parenchymal transection-induced rapid liver regenerationYifan Tong, Qiuxia Gu, Bingzhi Dong, et al.
Cell Death & Disease|March 11, 2018
ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinomaLongbo Zheng, Ming Xu, Junjie Xu, et al.
Surgery Today|July 1, 2019
End-to-end intestinal anastomosis using a novel biodegradable stent for laparoscopic colonic surgery: a multicenter studyMingyu Chen, Jiasheng Cao, Diyu Huang, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 7, 2021
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib ResistanceShunjie Xia, Lin Ji, Liye Tao, et al.
Heliyon|February 5, 2024
Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk modelJing He, Weiqi Li, Weijun Zhao, et al.
Materials Today. Bio|October 24, 2024
Recent research progresses of bioengineered biliary stentsJianing Yan, Zhichao Ye, Xiaofeng Wang, et al.
Pageof 30

Showing results (211-220 of 299) with videos related to

Sort By:
Pageof 30
Annals of Translational Medicine|November 4, 2020
Association of circulating 25-Hydroxyvitamin D and its related genetic variations with hepatocellular carcinoma incidence and survivalHui Liu, Xia Jiang, Qiaohua Qiao, et al.
Cell Communication and Signaling : CCS|July 16, 2022
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growthJiahao Hu, Jiasheng Cao, Ren'an Jin, et al.
Molecular Cancer Therapeutics|March 5, 2016
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC ProgressionLiang Shi, Hui Lin, Gonghui Li, et al.
Aging|June 25, 2020
Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinomaGuangyi Jiang, Liang Shi, Xueyong Zheng, et al.
Surgery|March 29, 2025
Beta-catenin/sirtuin 1/farnesoid X receptor pathway promotion of portal vein ligation and parenchymal transection-induced rapid liver regenerationYifan Tong, Qiuxia Gu, Bingzhi Dong, et al.
Cell Death & Disease|March 11, 2018
ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinomaLongbo Zheng, Ming Xu, Junjie Xu, et al.
Surgery Today|July 1, 2019
End-to-end intestinal anastomosis using a novel biodegradable stent for laparoscopic colonic surgery: a multicenter studyMingyu Chen, Jiasheng Cao, Diyu Huang, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 7, 2021
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib ResistanceShunjie Xia, Lin Ji, Liye Tao, et al.
Heliyon|February 5, 2024
Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk modelJing He, Weiqi Li, Weijun Zhao, et al.
Materials Today. Bio|October 24, 2024
Recent research progresses of bioengineered biliary stentsJianing Yan, Zhichao Ye, Xiaofeng Wang, et al.
Pageof 30